A forum to discuss Chronic Cerebrospinal Venous Insufficiency and its relationship to Multiple Sclerosis.
Post Reply
User avatar
Family Elder
Posts: 825
Joined: Sat Oct 19, 2013 10:17 am
Location: Czech Republic


Post by Petr75 » Wed Feb 05, 2020 11:50 am

2019 Dec 30
Department of Radiology, Hospital Universitario Quironsalud, Madrid, Spain
Early Perfusion Changes in Multiple Sclerosis Patients as Assessed by MRI Using Arterial Spin Labeling ... -labeling/


Background: Gadolinium-perfusion magnetic resonance (MR) identifies gray matter abnormalities in early multiple sclerosis (MS), even in the absence of structural differences. These perfusion changes could be related to the cognitive disability of these patients, especially in the working memory. Arterial spin labeling (ASL) is a relatively recent perfusion technique that does not require intravenous contrast, making the technique especially attractive for clinical research.
Purpose: To verify the perfusion alterations in early MS, even in the absence of cerebral volume changes. To introduce the ASL sequence as a suitable non-invasive method in the monitoring of these patients.
Material and methods: Nineteen healthy controls and 28 patients were included. The neuropsychological test EDSS and SDMT were evaluated. Cerebral blood flow and bolus arrival time were collected from the ASL study. Cerebral volume and cortical thickness were obtained from the volumetric T1 sequence. Spearman's correlation analyzed the correlation between EDSS and SDMT tests and perfusion data. Differences were considered significant at a level of P < 0.05.
Results: Reduction of the cerebral blood flow and an increase in the bolus arrival time were found in patients compared to controls. A negative correlation between EDSS and thalamus transit time, and between EDSS and cerebral blood flow in the frontal cortex, was found.
Conclusion: ASL perfusion might detect changes in MS patients even in absent structural volumetric changes. More longitudinal studies are needed, but perfusion parameters could be biomarkers for monitoring these patients.

Post Reply
  • Similar Topics
    Last post

Return to “Chronic Cerebrospinal Venous Insufficiency (CCSVI)”